VYNE THERAPEUTICS INC (VYNE) Stock Earnings & Estimates
NASDAQ:VYNE - US92941V3087 - Common Stock
0.3244 USD
0 (-0.55%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 480K -48.39% | 424K -11.67% | 501K 18.16% | 476.003K -4.99% | 306K -35.71% | -100.00% | 6.936M | 51M 635.29% | 102M 100.00% | 153M 50.00% | 204M 33.33% | |
| EBITDA YoY % growth | -34.23M 11.78% | -29.258M 14.53% | -43.633M -49.13% | -44.88M -2.86% | -51.714M -15.23% | -58.854M -13.81% | -62.526M -6.24% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -34.3M 11.85% | -29.258M 14.70% | -43.637M -49.15% | -41.106M 5.80% | -48.178M -17.20% | -67.677M -40.47% | -89.913M -32.86% | -129.54M -44.07% | -18.87M 85.43% | 31.11M 264.86% | 81.6M 162.30% | |
| Operating Margin | -7,145.83% | -6,900.47% | -8,709.98% | -8,635.65% | -15,744.44% | N/A | -1,296.32% | -254.00% | -18.50% | 20.33% | 40.00% | |
| EPS YoY % growth | -11.07 33.91% | -7.04 36.40% | -0.94 86.65% | -0.78 16.72% | -0.78 0.98% | -1.17 -50.66% | -2.50 -113.97% | -2.70 -8.16% | -0.41 84.91% | 0.56 237.50% | 1.38 145.45% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.20 30.83% | -0.21 25.93% | -0.22 -12.20% | -0.22 -72.62% | -0.22 -11.86% | -0.23 -13.12% |
| Revenue Q2Q % growth | 178.5K 47.52% | 178.5K 112.50% | 204K 0.99% | 204K 195.65% | 204K 14.29% | 204K 14.29% |
| EBITDA Q2Q % growth | -11.832M -19.59% | -12.852M -0.67% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -9.792M 25.20% | -9.996M 21.72% | -10.2M -10.91% | -10.404M -37.95% | -10.608M -8.33% | -10.812M -8.16% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.13 40.91% | -0.23 | 0.10 | 42.93% |
| Q1 2025 Q2Q % growth | -0.20 -33.33% | -0.30 | 0.10 | 32.39% |
| Q4 2024 Q2Q % growth | -0.28 -40.00% | -0.31 | 0.03 | 9.50% |
| Q3 2024 Q2Q % growth | -0.29 85.57% | -0.24 | -0.05 | -20.98% |
| Q2 2024 Q2Q % growth | -0.22 92.88% | -0.19 | -0.03 | -13.52% |
| Q1 2024 Q2Q % growth | -0.15 91.38% | -0.24 | 0.09 | 38.73% |
| Q4 2023 Q2Q % growth | -0.20 93.99% | -0.51 | 0.31 | 60.78% |
| Q3 2023 Q2Q % growth | -2.01 30.21% | -0.78 | -1.23 | -159.29% |
| Q2 2023 Q2Q % growth | -3.09 -32.05% | -2.03 | -1.06 | -52.23% |
| Q1 2023 Q2Q % growth | -1.74 30.95% | -2.66 | 0.92 | 34.64% |
| Q4 2022 Q2Q % growth | -3.33 7.50% | -3.30 | -0.03 | -0.76% |
| Q3 2022 Q2Q % growth | -2.88 55.56% | -3.18 | 0.30 | 9.50% |
| Q2 2022 Q2Q % growth | -2.34 62.86% | -3.12 | 0.78 | 25.03% |
| Q1 2022 Q2Q % growth | -2.52 -581.08% | -3.03 | 0.51 | 16.82% |
| Q4 2021 Q2Q % growth | -3.60 -554.55% | -4.35 | 0.75 | 17.15% |
| Q3 2021 Q2Q % growth | -6.48 -980.00% | -5.92 | -0.56 | -9.44% |
| Q2 2021 Q2Q % growth | -6.30 -687.50% | -6.50 | 0.20 | 3.07% |
| Q1 2021 Q2Q % growth | -0.37 90.26% | -0.42 | 0.05 | 11.09% |
| Q4 2020 Q2Q % growth | -0.55 84.55% | -0.55 | 0.00 | -0.60% |
| Q3 2020 Q2Q % growth | -0.60 78.57% | -0.68 | 0.08 | 12.01% |
| Q2 2020 Q2Q % growth | -0.80 71.01% | -1.01 | 0.21 | 21.04% |
| Q1 2020 Q2Q % growth | -3.80 -17.28% | -2.20 | -1.60 | -72.48% |
| Q4 2019 Q2Q % growth | -3.56 | -3.37 | -0.19 | -5.64% |
| Q3 2019 Q2Q % growth | -2.80 | -3.15 | 0.35 | 11.07% |
| Q2 2019 Q2Q % growth | -2.76 | -3.44 | 0.68 | 19.66% |
| Q1 2019 Q2Q % growth | -3.24 | -3.30 | 0.06 | 1.72% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 69K -65.15% | 153K | -84K | -54.90% |
| Q1 2025 Q2Q % growth | 202K 106.12% | 51K | 151K | 296.08% |
| Q4 2024 Q2Q % growth | 84K 10.53% | 142.8K | -58.8K | -41.18% |
| Q3 2024 Q2Q % growth | 121K 6.14% | 112.2K | 8.8K | 7.84% |
| Q2 2024 Q2Q % growth | 198K 46.67% | 112.2K | 85.8K | 76.47% |
| Q1 2024 Q2Q % growth | 98K -1.01% | 102K | -4K | -3.92% |
| Q4 2023 Q2Q % growth | 76K 660.00% | 153K | -77K | -50.33% |
| Q3 2023 Q2Q % growth | 114K -32.94% | 153K | -39K | -25.49% |
| Q2 2023 Q2Q % growth | 135K 3.85% | 102K | 33K | 32.35% |
| Q1 2023 Q2Q % growth | 99K -45.00% | 99K | % | |
| Q4 2022 Q2Q % growth | 10K 100.27% | 61.2K | -51.2K | -83.66% |
| Q3 2022 Q2Q % growth | 170K -95.84% | 135.997K | 34.003K | 25.00% |
| Q2 2022 Q2Q % growth | 130K -56.67% | 102K | 28K | 27.45% |
| Q1 2022 Q2Q % growth | 180K -21.74% | 374.003K | -194.003K | -51.87% |
| Q4 2021 Q2Q % growth | -3.68M -185.78% | 4.208M | -7.888M | -187.45% |
| Q3 2021 Q2Q % growth | 4.09M 25.08% | 4.857M | -767K | -15.79% |
| Q2 2021 Q2Q % growth | 300K -97.43% | 7.682M | -7.382M | -96.09% |
| Q1 2021 Q2Q % growth | 230K -86.86% | 5.413M | -5.183M | -95.75% |
| Q4 2020 Q2Q % growth | 4.29M | 4.801M | -511K | -10.64% |
| Q3 2020 Q2Q % growth | 3.27M | 3.318M | -48K | -1.45% |
| Q2 2020 Q2Q % growth | 11.69M | 2.472M | 9.218M | 372.90% |
| Q1 2020 Q2Q % growth | 1.75M 464.52% | 2.22M | -470K | -21.17% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 15.71% | 34.44% | 25.12% | 37.77% |
| Revenue | 0% | 75% | -33.33% | 133.34% |